Hang Seng China Enterprises Index ETF(02828.HK) Fell 0.32% to 88.440
Newtimespace News, as of 09:56 on May 20, Hang Seng China Enterprises Index ETF(02828.HK) was quoted at HKD 88.440, down 0.32%. The ETF opened at HKD 88.440, with a high of HKD 88.600 and a low of HKD 88.060. The latest Net Asset Value (NAV) per unit is HKD 88.693, with a premium rate of 0.03%. The asset size is approximately HKD 35.492 billion.
Hang Seng China Enterprises Index ETF(02828.HK) tracks the Hang Seng China Enterprises Index, which is compiled and published by Hang Seng Indexes Company Limited. The index aims to reflect the overall performance of Mainland Chinese enterprises (including H-shares, Red Chips, and private enterprises) listed in Hong Kong. As one of the first offshore indices representing the performance of Mainland Chinese enterprises, it has undergone multiple optimizations and adjustments. It currently consists mainly of the 50 securities with the largest market capitalization and highest liquidity, serving as a key barometer reflecting the trend of core Chinese assets listed in Hong Kong.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- PINESTONE (00804.HK): Net Proceeds of HKD 24.2 Million from Placing for Virtual Asset Licence Application and AI Application Expansion
- MICROTECH MED-B (02235.HK): Enters Raw Material Purchase Framework Agreement with Connected Person Hangzhou Shukang
- DETAI NEWENERGY (00559.HK): Enters Memorandum of Understanding for Proposed Acquisition of HKD 505 Million; Trading Remains Suspended
- SCIENTECH (02291.HK): Acquires 54.2384% Equity of Shanghai Minwei Biotechnology for RMB 1.088 Billion, Constituting Major and Connected Transaction
- CHINAHONGQIAO (01378.HK): Revises Annual Caps under Industrial Products Purchase Agreement, 2027 Cap Raised to RMB 26.24 Million